Page last updated: 2024-10-24

calmidazolium and Adenoma, Adrenal Cortical

calmidazolium has been researched along with Adenoma, Adrenal Cortical in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, Y1
Hattangady, NG1
Ye, P1
Satoh, F1
Morimoto, R1
Ito-Saito, T1
Sugawara, A1
Ohba, K1
Takahashi, K1
Rainey, WE1
Sasano, H1

Other Studies

1 other study available for calmidazolium and Adenoma, Adrenal Cortical

ArticleYear
Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA).
    Molecular and cellular endocrinology, 2014, Mar-25, Volume: 384, Issue:1-2

    Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Benzylamines; Calcium;

2014